Patient Guide: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 43 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04419649
Status: 🟢 Enrolling Now
Condition: Myelodysplastic Syndromes, Cytopenia
Phase: PHASE2

Where You Can Participate

This study is available at 43 locations across the country.

Top locations include:
  • • Duarte, California
  • • Miami, Florida
  • • Tampa, Florida
  • • And 40 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) - Join Clinical Trial NCTNCT04419649

How to Join This Clinical Trial - NCTNCT04419649

Learn how to participate in this PHASE2 trial studying an investigational therapy for Myelodysplastic Syndromes, Cytopenia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myelodysplastic Syndromes, Cytopenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myelodysplastic Syndromes, Cytopenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04419649 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 43 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: RECRUITING

Clinical Research Site

Lansing, Michigan 48910 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Pittsburgh, Pennsylvania 15213 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Albury, New South Wales 2640 - Australia

Status: RECRUITING

Clinical Research Site

Tweed Heads, New South Wales 2485 - Australia

Status: RECRUITING

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: RECRUITING

Clinical Research Site

Douglas, Queensland 4814 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia 5000 - Australia

Status: RECRUITING

And 33 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Myelodysplastic Syndromes, Cytopenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships